Madden Colm, Halsted Mark, Meinzen-Derr Jareen, Bardo Dianna, Boston Mark, Arjmand Ellis, Nishimura Carla, Yang Tao, Benton Corning, Das Vijay, Smith Richard, Choo Daniel, Greinwald John
Department of Audiovestibular Medicine, Manchester Royal Infirmary, Manchester, England.
Arch Otolaryngol Head Neck Surg. 2007 Feb;133(2):162-8. doi: 10.1001/archotol.133.2.162.
To correlate genetic and audiometric findings with a detailed radiologic analysis of the temporal bone in patients with enlarged vestibular aqueduct (EVA) to ascertain the contribution of SLC26A4 gene mutations to this phenotype.
A retrospective review of patients with EVA identified in a database of pediatric hearing-impaired patients.
A tertiary care pediatric referral center.
Seventy-one children with EVA and screening results for SLC26A4 mutations.
Genetic screening results, audiometric thresholds, and radiographic temporal bone measurements.
Seventy-one children with EVA were screened for SLC26A4 mutations. Mutations were found in 27% of children overall, while only 8% had biallelic mutations. The mean initial pure-tone average (PTA) was 59 dB; the mean final PTA was 67 dB. A bilateral EVA was found in 48 (67%) of the children; a unilateral EVA was found in 23 (33%). Progressive hearing loss (in at least 1 ear) was seen in 29 (41%) of the patients. The strongest genotype-phenotype interaction was seen in children with a bilateral EVA. Among children with SLC26A4 mutations, there was a significantly wider vestibular aqueduct at the midpoint and a wider vestibule width (P < .05) than in children without the mutation. Among patients with a bilateral EVA, children with any SLC26A4 mutation were more likely to have a more severe final PTA (64 dB vs 32 dB), larger midpoint measurement (2.1 vs 1.1 mm), and larger operculum measurement (3.0 vs 2.0 mm) than those without the mutation in their better-hearing ear (P < .05).
In a population of pediatric patients with an EVA and hearing loss, SLC26A4 mutations are a contributor to the phenotype. Our data suggest that other genetic factors also have important contributions to this phenotype. The presence of an abnormal SLC26A4 allele, even in the heterozygous state, was associated with greater enlargement of the vestibular aqueduct, abnormal development of the vestibule, and possibly a stable hearing outcome.
将扩大的前庭导水管(EVA)患者的基因和听力测定结果与颞骨的详细影像学分析相关联,以确定SLC26A4基因突变对该表型的影响。
对儿科听力受损患者数据库中确诊的EVA患者进行回顾性研究。
一家三级儿科转诊中心。
71例患有EVA且有SLC26A4基因突变筛查结果的儿童。
基因筛查结果、听力阈值和颞骨影像学测量。
对71例EVA患儿进行了SLC26A4基因突变筛查。总体上27%的儿童发现有突变,而仅有8%有双等位基因突变。初始纯音平均听阈(PTA)均值为59dB;最终PTA均值为67dB。48例(67%)患儿发现双侧EVA;23例(33%)发现单侧EVA。29例(41%)患者出现进行性听力损失(至少一只耳朵)。在双侧EVA患儿中观察到最强的基因型-表型相互作用。在有SLC26A4基因突变的儿童中,与无突变儿童相比,前庭导水管中点处明显更宽,前庭宽度更宽(P<0.05)。在双侧EVA患者中,与听力较好耳朵无突变的儿童相比,任何SLC26A4基因突变的儿童更可能有更严重的最终PTA(64dB对32dB)、更大的中点测量值(2.1对1.1mm)和更大的总脚测量值(3.0对2.0mm)(P<0.05)。
在患有EVA和听力损失的儿科患者群体中,SLC26A4基因突变是该表型的一个影响因素。我们的数据表明其他遗传因素对该表型也有重要影响。即使处于杂合状态,异常SLC26A4等位基因的存在也与前庭导水管更大程度的扩大、前庭的异常发育以及可能稳定的听力结果相关。